Tag : immune-mediated diseases

Clinical Research, Pharma & Healthcare Financing

Novartis provides update on Phase III GCAptAIN study of Cosentyx® in giant cell arteritis

PR Newswire
by PR Newswire086
Novartis today announced top-line results from the Phase III GCAptAIN study evaluating Cosentyx® (secukinumab) in adults with newly diagnosed or relapsing giant cell arteritis (GCA). In...
Healthcare Quality, Patient Safety & Policy

Bristol Myers Squibb Presents Sotyktu Data in PsA at 2025 AAD

Business Wire
by Business Wire0264
Significantly more patients treated with Sotyktu achieved ACR and PASI response rates and had greater improvements in patient-reported quality of life compared with placebo at Week 16 Sotyktu was...